Parkinson's disease: etiopathogenesis and treatment

J Jankovic, EK Tan - Journal of Neurology, Neurosurgery & Psychiatry, 2020 - jnnp.bmj.com
The concept of 'idiopathic'Parkinson's disease (PD) as a single entity has been challenged
with the identification of several clinical subtypes, pathogenic genes and putative causative …

Alzheimer's and Parkinson's disease therapies in the clinic

P Chopade, N Chopade, Z Zhao… - Bioengineering & …, 2023 - Wiley Online Library
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most prevalent
neurodegenerative diseases, affecting millions and costing billions each year in the United …

[PDF][PDF] Parkinson disease epidemiology, pathology, genetics, and pathophysiology

DK Simon, CM Tanner, P Brundin - Clinics in geriatric medicine, 2020 - Elsevier
SYNOPSIS (1 paragraph): Parkinson's disease (PD) is a complex age-related
neurodegenerative disease associated with dopamine deficiency and both motor and …

[HTML][HTML] Hypoxia and brain aging: Neurodegeneration or neuroprotection?

J Burtscher, RT Mallet, M Burtscher, GP Millet - Ageing research reviews, 2021 - Elsevier
The absolute reliance of the mammalian brain on oxygen to generate ATP renders it acutely
vulnerable to hypoxia, whether at high altitude or in clinical settings of anemia or pulmonary …

The ageing brain: molecular and cellular basis of neurodegeneration

S Azam, ME Haque, R Balakrishnan, IS Kim… - Frontiers in cell and …, 2021 - frontiersin.org
Ageing is an inevitable event in the lifecycle of all organisms, characterized by progressive
physiological deterioration and increased vulnerability to death. Ageing has also been …

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's …

J Fang, P Zhang, Y Zhou, CW Chiang, J Tan, Y Hou… - Nature aging, 2021 - nature.com
We developed an endophenotype disease module-based methodology for Alzheimer's
disease (AD) drug repurposing and identified sildenafil as a potential disease risk modifier …

α-synuclein in the pathophysiology of Alzheimer's disease

D Twohig, HM Nielsen - Molecular neurodegeneration, 2019 - Springer
The Alzheimer's disease (AD) afflicted brain is neuropathologically defined by extracellular
amyloid-β (Aβ) plaques and intraneuronal neurofibrillary tangles composed of …

CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease

J Galiano-Landeira, A Torra, M Vila, J Bové - Brain, 2020 - academic.oup.com
There is no consensus on the exact role of the adaptive immune system in Parkinson's
disease pathogenesis, although there is increasing evidence that it is somehow involved …

Potential role of mitochondria-associated endoplasmic reticulum membrane proteins in diseases

H Mao, W Chen, L Chen, L Li - Biochemical pharmacology, 2022 - Elsevier
Mitochondria-associated endoplasmic reticulum membranes (MAMs) are dynamic
membrane coupling regions formed by the coupling of the mitochondrial outer membrane …

[HTML][HTML] Overlap** neuroimmune mechanisms and therapeutic targets in neurodegenerative disorders

F De Marchi, I Munitic, L Vidatic, E Papić, V Rački… - Biomedicines, 2023 - mdpi.com
Many potential immune therapeutic targets are similarly affected in adult-onset
neurodegenerative diseases, such as Alzheimer's (AD) disease, Parkinson's disease (PD) …